Verona Pharma's total assets for Q1 2025 were £525.94M, an increase of 10.90% from the previous quarter. VRNA total liabilities were £299.34M for the fiscal quarter, a 11.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.